Showing results (1-10 of 617) with videos related to
Sort By:
Pageof 62
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1996
In vitro activity and selection of disk content for disk diffusion susceptibility tests with trovafloxacinP C Fuchs, A L Barry, S D Brown, et al.Antimicrobial Agents and Chemotherapy|July 1, 1995
Antibacterial activity of WY-49605 compared with those of six other oral agents and selection of disk content for disk diffusion susceptibility testingP C Fuchs, A L Barry, D L SewellThe Journal of Antimicrobial Chemotherapy|June 22, 2001
Interpretative criteria and quality control parameters for telithromycin disc diffusion susceptibility testsA L Barry, P C Fuchs, S D BrownAntimicrobial Agents and Chemotherapy|May 17, 2001
In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centersP C Fuchs, A L Barry, S D BrownEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 29, 1999
Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility testsA L Barry, P C Fuchs, S D BrownJournal of Clinical Microbiology|January 1, 1997
Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC GroupP C Fuchs, A L Barry, S D BrownDiagnostic Microbiology and Infectious Disease|April 1, 1996
Survey of antimicrobial activity of four commonly used third generation cephalosporins tested against recent bacterial isolates from ten American medical centers, and assessment of disk diffusion test performance. AST Surveillance GroupP C Fuchs, A L Barry, S D BrownThe Journal of Antimicrobial Chemotherapy|December 16, 1998
Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centresA L Barry, P C Fuchs, S D BrownThe Journal of Antimicrobial Chemotherapy|May 1, 1997
Provisional interpretive criteria for quinupristin/dalfopristin susceptibility testsA L Barry, P C Fuchs, S D BrownAntimicrobial Agents and Chemotherapy|April 29, 1998
Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin)A L Barry, P C Fuchs, S D BrownPageof 62